NDRI Welcomes Tom Malecki as New Chief Financial Officer and Vice President of Administration

The National Disease Research Interchange (NDRI) is pleased to welcome Tom Malecki as its new Chief Financial Officer and Vice President of Administration. Malecki brings a wealth of experience and has a proven track record in financial leadership across several industries. He will be responsible for overseeing the organization’s financial operations and playing a crucial role in advancing NDRI’s mission.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230926260799/en/

NDRI welcomes to the team our new CFO Tom Malecki. (Photo: Business Wire)

“I’m excited to join the talented professionals advancing research at NDRI,” says Malecki. “It’s exciting to help our partners fulfill their research needs in all sectors of research - government, corporate, academic, both domestically and internationally.”

Malecki joins NDRI with over 30 years of experience in finance and operations. His leadership positions span the retail, government, pharmaceutical, and nonprofit sectors. Prior to joining NDRI, Malecki served as the Chief Operations Officer and Chief Financial Officer at the Utility Emergency Services Fund (UESF), a Philadelphia based nonprofit dedicated to assisting families facing difficulties finding stable housing. Malecki started his career with the Arthur Andersen organization, an accounting firm based out of Chicago.

Malecki holds an MBA in Accounting from LaSalle University in Philadelphia and a Bachelor’s degree in Accounting from Albright College. He has served on various nonprofit boards, including the Board of Trustees for The Woodlynde School and the Country Club Swim Association. He has also served on the MBA Advisory Committee and taught as an Adjunct Professor at LaSalle University School of Business.

“We are thrilled to have Tom as a member of our management team at NDRI,” says Bill Leinweber, President and CEO of NDRI. “His experience will add great value to financial and critical administrative functions of information technology and human resources.”

About NDRI

The National Disease Research Interchange (NDRI) is the nation’s leading source of human tissues, cells and organs for scientific research. A not-for-profit 501 (c) (3) organization founded in 1980, NDRI is funded in part by the National Institutes of Health, public and private foundations and organizations, pharmaceutical and biotechnology corporations. NDRI is a 24/7 operation that partners with a nationwide network of over 130 tissue source sites (TSS), including organ procurement organizations (OPOs), tissue banks, eye banks, and hospitals. The TSS, are distributed throughout the USA, in 45 states, with concentrations in major metropolitan areas on both the east and west coasts. Their wide geographic distribution allows NDRI to provide biospecimens from donor populations with diverse demographics and facilitates the timely and efficient provision of fresh tissues directly to researchers across the U.S. and around the world. By serving as the liaison between procurement sources and the research community, NDRI is uniquely positioned to support breakthrough advances and discoveries that can affect advances in the treatment and cure of human diseases.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230926260799/en/